E & E News, March 24, 2021: Consumers trying to avoid toxic chemicals in their nonstick cookware face convoluted advertising claims that can confuse even the most well-informed buyers. Take Diana Zuckerman, who, as president of the National Center for Health Research, is more familiar than the average person with chemistry and toxicology. Still, she said, trying to determine which pans and cookware did not contain PFAS, a class of toxic substances linked to cancer and other health problems, was no easy task.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Avoiding the Subject: On Pfizer Vaccine Quality Control, FDA Says Less than European Counterpart
Project on Government Oversight, March 19, 2021: The Project on Government Oversight’s new report about the Pfizer COVID Vaccine raises questions about why the FDA did not publicly disclose quality control concerns that were publicly raised in Europe. We ask: Is “adequate” quality control good enough?
Read More »Birth Control Apps Show the Contradictions in FDA Device Oversight
The Verge, March 17, 2021: The FDA has allowed a second digital birth control app to be sold in the U.S. Neither Natural Cycles nor Clue were tested in clinical trials. NCHR asks how safe and effective are they, and are women being misled?
Read More »The Differences Between the Vaccines Matter
The Atlantic, March 7, 2021: Public-health officials are enthusiastic about all 3 COVID-19 vaccines available in the U.S. For example, Virginia’s vaccine coordinator stated, “A hundred percent efficacy against deaths and hospitalizations? That’s all I need to hear.” But experts, including NCHR, point out that there were too few people with severe COVID in the vaccine studies to draw conclusions.
Read More »Janet Woodcock revolutionized the way the FDA reviews cancer drugs, inspiring her supporters and raising concerns for detractors
STAT News, March 1, 2021: The FDA is approving more new cancer drugs than ever before, after FDA’s drug chief Janet Woodcock loosened FDA standards. Now cancer doctors are Woodcock’s most vocal backers in her campaign to be FDA Commissioner. But critics say too many approved cancer drugs aren’t proven to help patients live longer.
Read More »